ClinicalTrials.gg
RecruitingNCT07363772HEROS 4Updated Apr 28, 2026

Evaluation of Mixed Reality Cardiopulmonary Resuscitation Training

An interventional study of HEROS 4.0 and Conventional CPR training in Cardiopulmonary Resuscitation (CPR), Basic Life Support Training Course and Cardiac Arrest (CA), sponsored by Seoul National University Hospital. Recruiting at 1 site in South Korea. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 12 studies in Heart Arrest by Seoul National University Hospital — 4 open to participants now, 5 under way, none of them phase 3. Heart Arrest · Seoul National University Hospital.

Started
2026
the only one that year
No phase
8 of 12
3 open now
Registered
12th of 12
by date

Among the 12 studies in Heart Arrest by Seoul National University Hospital, this one is the only one that started in 2026, is one of 8 with no phase, and was the 12th registered.

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Open to participants now

4 of the 12 studies in Heart Arrest by Seoul National University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Heart Arrest by Seoul National University Hospital, or all of them as a file.
02

Study summary

\<Study Design> This study is a cluster-randomized, stratified, non-inferiority trial designed to evaluate the feasibility, efficacy, and educational effectiveness of HEROS 4.0, a mixed-reality (MR)-based cardiopulmonary resuscitation (CPR) training system, compared with conventional instructor-led CPR training.

\<Objective \& Hypothesis> The primary objective is to determine whether MR-based HEROS 4.0 CPR training is non-inferior to standard video- and instructor-based CPR training in improving CPR performance quality. The central hypothesis is that participants trained using HEROS 4.0 will achieve comparable CPR quality to those trained using traditional methods, while benefiting from enhanced immersion, scalability, and accessibility.

\<Participants> A total of 120 adults aged 18-50 years who have not received CPR training within the previous 12 months will be recruited. Participants will be assigned to one of two clusters and randomized in a 1:1 ratio to either the HEROS 4.0 MR training group or the conventional CPR training group.

\<Intervention \& Control>

Participants will undergo CPR training according to their assigned group:

Intervention group (HEROS 4.0):

Participants will receive a two-stage CPR training program consisting of pre-training and on-site MR-based training. As pre-training, participants will be instructed to watch a 40-minute instructional video (conventional CPR training group video) at home prior to their visit. After completing the pre-training, participants will undergo 20 minutes of MR-based CPR training using the HEROS 4.0 system in a dedicated CPR training booth.

Control group (Conventional CPR training):

Participants will receive 60 minutes of standard CPR education delivered through instructional videos and in-person instructor guidance, reflecting current community CPR training practice.

\<Outcomes> Immediately after training, all participants will undergo a standardized cardiac arrest simulation using a CPR quality-measurement manikin. This simulation will assess objective CPR performance metrics as well as subjective outcomes through questionnaires.

To evaluate knowledge retention and skill durability, all assessments will be repeated 6 months after training using the same simulation scenario and outcome measures.

The primary outcome is chest compression fraction measured during the standardized simulated cardiac arrest scenario.

Secondary outcomes include quantitative measures of CPR quality and participant-reported outcomes based on survey.

03

Conditions studied

  • Cardiopulmonary Resuscitation (CPR)
  • Basic Life Support Training Course
  • Cardiac Arrest (CA)

Browse trials for

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-50 years who have not received CPR training within the previous 12 months.

Exclusion criteria

Exclusion Criteria:

  • Healthcare professionals
  • Individuals unable to safely tolerate MR equipment (e.g. motion sickness)
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    HEROS 4.0

    Participants will receive a two-stage CPR training program consisting of pre-training and on-site MR-based training. As pre-training, participants will be instructed to watch a 40-minute instructional video (conventional CPR training group video) at home prior to their visit. After completing the pre-training, participants will undergo 20 minutes of MR-based CPR training using the HEROS 4.0 system in a dedicated CPR training booth.

    Other: HEROS 4.0

  • Active comparator
    Conventional CPR training

    Participants will receive 60 minutes of standard CPR education delivered through instructional videos and in-person instructor guidance, reflecting current community CPR training practice.

    Other: Conventional CPR training

Interventions

  • OtherHEROS 4.0

    Participants will receive a two-stage CPR training program consisting of pre-training and on-site MR-based training. As pre-training, participants will be instructed to watch a 40-minute instructional video (conventional CPR training group video) at home prior to their visit. After completing the pre-training, participants will undergo 20 minutes of MR-based CPR training using the HEROS 4.0 system in a dedicated CPR training booth. The MR-based CPR training content consists of cardiac arrest recognition, calling emergency medical services, chest compressions, and use of an automated external defibrillator, while minimizing interruptions in chest compressions.

  • OtherConventional CPR training

    Participants will receive 60 minutes of standard CPR education delivered through instructional videos and in-person instructor guidance, reflecting current community CPR training practice.

06

What researchers measure

Primary outcomes

  1. Chest compression fraction

    Chest compression fraction (CCF) is defined as the proportion of total resuscitation time during which chest compressions are actively delivered. Chest compression quality metrics including CCF will be measured during a standardized cardiac arrest simulation using a CPR quality-measurement manikin.

    Time frame: (1) Immediately after training and (2) at 6-month follow-up.

Secondary outcomes

  1. Mean chest compression depth

    The average depth of all chest compressions delivered during the simulated resuscitation.

    Time frame: (1) Immediately after training and (2) at 6-month follow up.

  2. Mean chest compression rate

    The average number of chest compressions performed per minute during the CPR simulation.

    Time frame: (1) Immediately after training and (2) at 6-month follow up.

  3. Proportion of compressions with adequate depth

    The percentage of chest compressions that meet guideline-recommended depth (5-6 cm) criteria during the simulation.

    Time frame: (1) Immediately after training and (2) at 6-month follow up.

  4. Proportion of compressions with adequate rate

    The percentage of chest compressions that fall within the guideline-recommended (100-120 compressions per minute) compression rate range.

    Time frame: (1) Immediately after training and (2) at 6-month follow up.

  5. Overall basic life support performance

    Measurement of basic life support performance during standardized cardiac arrest simulation using the following checklist items including: Check response / Assess breathing / Call EMS and get help / Chest compressions / Activate AED and attach pads / Stand clear / Deliver shock / Minimize CPR interruptions /

    Time frame: (1) Immediately after training and (2) at 6-month follow up.

  6. CPR self-efficacy

    Participants' self-efficacy in performing CPR will be evaluated using a modified version of the Basic Resuscitation Skills Self-Efficacy Scale (BRS-SES), consisting of 15 items rated on a 11-point Likert scale (converted to 0-100 scale), with higher scores indicating greater self-efficacy.

    Time frame: (1) Before training, (2) immediately after training and (3) at 6-month follow-up.

  7. System Usability Scale

    The usability of the MR-based CPR Training program will be evaluated using the System Usability Scale (SUS), a validated 10-item questionnaire rated on a 5-point Likert scale, with higher scores indicating better usability. This assessment will be conducted only in the experimental group.

    Time frame: Immediately after training

07

Study locations

1 of 1 sites recruiting
  • Nowon-gu Public Health Center
    Seoul, Nowon-gu 01689, South Korea
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 10 months after the start.

Of 205 non-industry interventional studies with no phase under Heart Arrest, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 47. This study's planned 10 months is below that.

Counting every sponsor, half of 219 studies reached it within 28 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2026
First posted
Jan 23, 2026
StartActual
Feb 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2027
Last update
Apr 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07363772
Responsible party
Ki Jeong Hong (Professor, Seoul National University Hospital) — Principal investigator
First posted
Jan 23, 2026
Start date
Feb 1, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 28, 2026

Study contacts

Dong Hyun Choi, MD, PhD
Contact
donghyun369@naver.com
82-2-2072-4646
Sang Do Shin, MD, PhD
study chair · Seoul National University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion